TipRanks
Go Ultimate55% OFF

Kailera Therapeutics, Inc. (KLRA) Financial Statements

Kailera Therapeutics, Inc. Financial Overview

Kailera Therapeutics, Inc.'s market cap is currently $1.67B. The company's EPS TTM is $-1.76; its P/E ratio is -7.31; Kailera Therapeutics, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25
Income Statement
Total Revenue$ 0.00
Gross Profit$ 0.00
Operating Income$ -158.34M
EBITDA$ -158.03M
Net Income$ -148.96M
Balance Sheet
Cash & Short-Term Investments$ 546.06M
Total Assets$ 692.29M
Total Debt$ 10.75M
Net Debt$ -149.51M
Total Liabilities$ 1.05B
Stockholders' Equity$ -356.46M
Cash Flow
Free Cash Flow$ -122.30M
Operating Cash Flow$ -120.21M
Investing Cash Flow$ -492.60M
Financing Cash Flow$ 598.66M

Currency in USD

Kailera Therapeutics, Inc. Earnings and Revenue History

-180M-120M-60M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2025RevenueEarningsProfit Margin

Kailera Therapeutics, Inc. Debt to Assets

0400M800M1.2B150 %151 %152 %153 %LiabilitiesDebt to Assets2025AssetsLiabilitiesDebt to Assets

Kailera Therapeutics, Inc. Cash Flow

-750M-500M-250M0250M500M750M2025OperatingInvestingFinancing

Kailera Therapeutics, Inc. Forecast EPS vs Actual EPS

-5K-4K-3K-2K-1K01KQ1 26Q2 26Q1 27EPS EstimateBeatMiss